Q2 EPS Forecast for Tenax Therapeutics Lowered by Analyst
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities research analysts at Roth Capital cut their Q2 2025 EPS estimates for shares of Tenax Therapeutics in a research report issued to clients and investors on Wednesday, May 14th. Roth Capital analyst J. Aschoff now forecasts that the specialty pharmaceutical company will post earnings per share […]
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities research analysts at Roth Capital cut their Q2 2025 EPS estimates for shares of Tenax Therapeutics in a research report issued to clients and investors on Wednesday, May 14th. Roth Capital analyst J. Aschoff now forecasts that the specialty pharmaceutical company will post earnings per share […]
